4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000899243-18-029962
Chief Executive Officer gave up 741 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
Kulkarni Samarth · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-12-01 | Shares withheld for taxes : show line 1 in the form | −741 | $38.33 | $28,403 | 145,790 | D |
Loading xslF345X03/doc4.xml…